/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

R

Ross A. Baker

Bristol-Myers Squibb (United States)(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

149

Papers

4.2K

Citations

36

h-index

82

i10-index

Ross A. Baker is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Schizophrenia research and treatment & Treatment of Major Depression & Bipolar Disorder and Treatment. The author has an h-index of 36, co-authored 127 publications.

ORCID: 0000-0001-5256-0470

Research Topics

Schizophrenia research and treatment Treatment of Major Depression Bipolar Disorder and Treatment Health Systems, Economic Evaluations, Quality of Life Attention Deficit Hyperactivity Disorder

Papers by this author

works

Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help

1997 · The Journal of Immunology · 430 citations

https://doi.org/10.4049/jimmunol.158.9.4200

V M Sanders Ross A. Baker D S Ramer-Quinn Deborah J. Kasprowicz

Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production

1997 · The Journal of Immunology · 211 citations

https://doi.org/10.4049/jimmunol.159.10.4857

D S Ramer-Quinn Ross A. Baker V M Sanders

Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis

2014 · Journal of Medical Economics · 48 citations

https://doi.org/10.3111/13696998.2014.979936

John M. Kane Cathy Zhao B. Johnson Ross A. Baker

Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release

2006 · Journal of Clinical Psychopharmacology · 47 citations

https://doi.org/10.1097/01.jcp.0000194622.99986.d6

Otto Benkert Armin Szegedi Michael Philipp Ralf Kohnen

Efficacy of adjunctive aripiprazole in patients with major depressive disorder who showed minimal response to initial antidepressant therapy

2012 · International Clinical Psychopharmacology · 42 citations

https://doi.org/10.1097/yic.0b013e3283502791

J. Craig Nelson Michael E. Thase Elizabeth E. Bellocchio Linda M. Rollin

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study

2014 · BMC Research Notes · 28 citations

https://doi.org/10.1186/1756-0500-7-459

Anita H. Clayton Ross A. Baker John J. Sheehan Zachary Cain

Research topics

topics

Schizophrenia research and treatment

Treatment of Major Depression

Bipolar Disorder and Treatment

Health Systems, Economic Evaluations, Quality of Life

Attention Deficit Hyperactivity Disorder

Chat about Author

Papers

Chat

Click to start Chat